Effect of dexmedetomidine and ketamine in deep anesthesia

Phase 2

• Conditions: Abnormalities of the spine.; Disease of spinal cord, unspecified; G95.9

• Registration Number: IRCT20240507061698N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Age 20 to 60 years
Patients with ASA CLASS 1 & 2
Patients who consent to participate in the study

Exclusion Criteria

Patients with severe heart disease
Patients with severe pulmonary and respiratory problems
Patients with kidney failure, fever, infection, electrolyte disorder, acid-base disorder, allergy to the studied drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relaxation level. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: RAMSEY criterion.;Level of consciousness. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: bispectral index (BIS) criterion.;Vital signs. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: Vital signs monitor.